PharmaceuticalsNews on pharmaceuticals
Drugs giant GlaxoSmithKline has been accused by the competition watchdog of paying firms to delay the launch of cheaper versions of its antidepressant treatment, in a move which denied the NHS “significant” cost savings.
NHS England today confirmed that it had taken some cancer treatments off its “fast track” list following changes to the cancer drugs fund announced yesterday.
HM Revenue and Customs is examining hospital trusts’ tax arrangements amid a growing trend to lawfully avoid paying VAT on outpatient drugs, HSJ has learned.
Pharmaceutical and technology companies looking to introduce their products into the NHS must do more research to demonstrate effectiveness, a senior NHS Commissioning Board official has said.
This week’s HSJ Briefing looks at primary care rebate schemes which, it is hoped, will lead to savings on drugs bills
The government is to hold talks with the pharmaceutical industry on the role of the National Institute for Heath and Clinical Excellence, in a bid to reach agreement on new pricing arrangements.
At least 30 per cent of primary care trusts are defying the Department of Health to set up discount deals with pharmaceutical companies, an HSJ investigation has found.
FINANCE: The Southampton, Hampshire, Isle of Wight and Portsmouth primary care trust cluster expects to save £10.2m through medicines management this year.
FINANCE: GPs in seven North East primary care trusts are prescribing paracetamol at twice the expected rate and could save the NHS an estimated £2.5m a year by their bringing reducing to the national average, the healthcare analysis firm CHKS has said.
PERFORMANCE: Northumbria Healthcare Foundation Trust has launched a team to review use of medication in case homes.
The NHS Commissioning Board’s plans to develop national policies for new treatments after just five individual funding requests could stifle innovation, it has been warned.
Swift action is needed to ensure a smooth changeover to a new system of pricing for the drugs used by the NHS, the Commons health committee has said in a report today.
The huge disparity in uptake of medicines and technologies across the NHS has been laid bare by the first “innovation scorecard”.
Thousands of people with a devastating eye condition could be offered a potentially sight-saving treatment following a U-turn by the health watchdog.
NICE approves Lucentis and the rest of today’s news
Doctors could save the NHS billions of pounds a year by ditching expensive branded drugs in favour of prescribing cheaper, equally effective alternatives, new research has found.
If pharmacists fail to grasp the opportunities before them, someone else will
Lack of transparency in the medicines supply chain is of concern to many observers
HIECs are invaluable in delivering improvement at scale and pace
By partnering with a pharmaceutical firm an East Midlands trust became the first in the region to achieve a major target for VTE risk assessment. Scott Savage explains.
Preventing unnecessary hospital admissions for medication could save the NHS a significant part of the £150m “medicine waste” recognised in a Department of Health report, say Nina Barnett and Andrew McDowell.
Providing GPs with the right support on prescribing can realistically deliver savings for CCGs in their prescription budgets that could make a significant dent in an annual NHS spend of £8bn a year, says Claire Forde.